Document Type : Original Article(s)
Authors
1
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2
Department of Biophysics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
3
Department of Radiotherapy, Iran University of Medical Sciences (IUMS), Tehran, Iran
4
Department of Photo Healing and Regeneration, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
5
Department of Medical Laser, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
Abstract
Background: Radiotherapy is a frequently used therapeutic modality for breast cancer. Dalbergin, a natural antioxidant, inhibits carcinogens and tumor progression. In the present study, we investigated the effect of Dalbergin on the response of T47D and MDA-MB-231 breast cancer cell lines to ionizing radiation.
Method: In this experimental in vitro study, doubling time of T47D and MDAMB- 231 were obtained from the growth curve. The cytotoxic effect of Dalbergin on T47D and MDA-MB-231 breast cancer cells were estimated via MTT assay. To determine the clonogenic ability, we treated T47D and MDA-MB-231 with Dalbergin for 48 h prior to irradiation, subsequent to which a colony assay was performed. Real-time polymerase chain reaction was employed to determine the gene expression level.
Results: Dalbergin inhibited proliferation of T47D and MDA-MB-231 in a time and concentration-dependent manner. Additionally, the most appropriate time for the treatment of these types of cancer cells was found to be 48 h and the drug's concentration in both cell lines was different. The IC50 values of T47D and MDA-MB-231 cells were 0.001 and 0.0001 μM, respectively. Moreover, this drug radiaosensitizes both cell lines effectively compared with the radiation only. Finally, the gene expression level of p53, Bcl-2, and STAT3 were investigated in cancer cells.
Conclusion: Dalbergin showed apoptotic effects probably through the STAT/p53 signaling pathway. Therefore, Dalbergin could be considered as a radiosensitizer and its effects may be owing to increased cell death.
Keywords
How to cite this article:
Mahdizade Valojerdi F, Goliaei B, Rezakhani N, Nikoofar A, Keshmiri Neghab H, Soheilifar MH, et al. In vitro radiosensitization of T47D and MDA-MB-231 breast cancer cells with the Neoflavonoid Dalbergin. Middle East J Cancer. 2023;14(2):205-18. doi: 10.30476/mejc.2022 .91913.1637.